Register for our free email digests:
Latest From Matrix-Bio Inc.
Derived from Strategic Transactions, Elsevier Business Intelligence’s premium source for tracking life sciences deal activity, the Medical Device Deals Update column is a survey of recent medtech M&A, Alliance, and Financing activity.
Derived from Strategic Transactions, Elsevier Business Intelligence’s premium source for tracking life sciences deal activity, the Tech Transfers column provides a monthly update on licensing agreements between companies and universities or other research institutions within the In Vitro Diagnostics, Medical Devices, and Pharmaceuticals sectors.
In Vitro Diagnostics
- Chemistry, Immunoassay
- Molecular Diagnostics & Genetic Testing
- Therapeutic Drug Monitoring
- Therapeutic Areas
- North America
- Parent & Subsidiaries
- Matrix-Bio Inc.
- Senior Management
Eric Beier, MD, CEO
Daniel Raftery, PhD, CSO
- Contact Info
10351 Dawson's Creek Blvd.
Fort Wayne, IN 47825
You must sign in to use this functionality
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.